Genome-Wide Association Studies in Glioma

@article{Kinnersley2018GenomeWideAS,
  title={Genome-Wide Association Studies in Glioma},
  author={Ben Kinnersley and Richard S. Houlston and Melissa L Bondy},
  journal={Cancer Epidemiology, Biomarkers \& Prevention},
  year={2018},
  volume={27},
  pages={418 - 428}
}
Since the first reports in 2009, genome-wide association studies (GWAS) have been successful in identifying germline variants associated with glioma susceptibility. In this review, we describe a chronological history of glioma GWAS, culminating in the most recent study comprising 12,496 cases and 18,190 controls. We additionally summarize associations at the 27 glioma-risk SNPs that have been reported so far. Future efforts are likely to be principally focused on assessing association of… Expand
Transcriptome-wide Mendelian randomization study prioritising novel tissue-dependent genes for glioma susceptibility
TLDR
This work integrated multi-tissue expression quantitative trait loci and glioma GWAS data and identified robust causal evidence for 12 genes andglioma risk, three of which are novel. Expand
Use of Mendelian Randomization for Identifying Risk Factors for Brain Tumors
TLDR
Mendelian randomization is described and its potential use to discover and validate novel risk factors, mechanistic factors, and therapeutic targets in glioma is described. Expand
Genetic variants in MIR17HG affect the susceptibility and prognosis of glioma in a Chinese Han population
TLDR
It is reported that MIR17HG rs7318578 was a risk factor forglioma susceptibility and rs17735387 was associated with the longer survival of glioma among Chinese Han population, which might help to enhance the understanding of MIR 17HG gene in gliomagenesis. Expand
Genome-wide association study across pediatric central nervous system tumors implicates shared predisposition and points to 1q25.2 (PAPPA2) and 11p12 (LRRC4C) as novel candidate susceptibility loci
TLDR
Variations in genetic loci with roles in CNS development appear to be involved, possibly via altered IGF-I related pathways. Expand
The Influence of NDRG1 Single Nucleotide Polymorphisms on Glioma Risk and Prognosis in Chinese Han Population.
TLDR
This study is the first to find that NDRG1 gene polymorphisms may have a certain association with glioma risk or prognosis in the Chinese Han population and the key factors for gliomas prognosis may include surgical operation, radiotherapy, and chemotherapy. Expand
A functional variant on 20q13.33 related to glioma risk alters enhancer activity and modulates expression of multiple genes
TLDR
Evidence is provided that rs3761124 is a functional variant on 20q13.33 related to glioma/GBM risk that modulates the expression of STMN3 and potentially other genes across diverse cellular contexts. Expand
Genetic Polymorphisms of CCDC26 rs891835, rs6470745, and rs55705857 in Glioma Risk: A Systematic Review and Meta-analysis
TLDR
The present findings suggest a possible participation of rs891835, rs6470745, and rs55705857 as risk factors to develop glioma, and it is possible that the involvement of CCDC26 variants depends on ethnicity. Expand
Meta-Analyses of Splicing and Expression Quantitative Trait Loci Identified Susceptibility Genes of Glioma
  • C. P. K. Patro, D. Nousome, Elizabeth B. Dora Joellen Jill S. Sara H. Jonine L. Christof Claus Il’yasova Schildkraut Barnholtz-Sloan Olson , R. Lai
  • Medicine
  • Frontiers in Genetics
  • 2021
TLDR
It is revealed that the regulation of transcriptome by glioma risk alleles is complex, with the potential for eQTL and sQTL jointly affecting gliomagenesis in risk loci, and quantitative trait loci that evaluate only total gene expression will miss many important target genes. Expand
A Functional Variant on 9p21.3 Related to Glioma Risk Affects Enhancer Activity and Modulates Expression of CDKN2B‐AS1
TLDR
expression quantitative trait loci analysis using non-diseased brain samples and analysis of Hi-C data generated in neural progenitor cells suggest rs1537372, a SNP at the 9p21.3 risk locus, is a functional variant that modulates expression of CDKN2B-AS1. Expand
The Genetic Changes of Hepatoblastoma
TLDR
The molecular epidemiology, especially SNPs progresses in hepatoblastoma, is reviewed and discussed to provide references for future studies and promote the study of hepatOBlastoma’s etiology. Expand
...
1
2
...

References

SHOWING 1-10 OF 136 REFERENCES
Quantifying the heritability of glioma using genome-wide complex trait analysis
TLDR
GCTA was applied to three GWAS datasets totalling 3,373 cases and 4,571 controls and performed a meta-analysis to estimate the heritability of glioma, indicating that most of the heritable risk attributable to common genetic variants remains to be identified. Expand
Genome-wide association study of glioma and meta-analysis
TLDR
These findings suggest that larger studies focusing on novel approaches as well as specific tumor subtypes or subgroups will be required to identify additional common susceptibility loci for glioma risk, and that the 85 most promising single nucleotide polymorphism (SNP) markers identified in this study were examined in three replication sets. Expand
Analysis of 60 Reported Glioma Risk SNPs Replicates Published GWAS Findings but Fails to Replicate Associations From Published Candidate‐Gene Studies
TLDR
The results of this case‐control study of Caucasian glioma cases and controls highlight that the deficiencies of the candidate‐gene approach lay in selecting both appropriate genes and relevant SNPs within these genes. Expand
Chromosome 7p11.2 (EGFR) variation influences glioma risk.
TLDR
Findings show that variation in 7p11.2 is a determinant of inherited glioma risk, independent of tumor subtype, and independent of EGFR amplification, p16INK4a deletion and IDH1 mutation status in tumors; compatible with driver effects of the variants on gliomas development. Expand
The Glioma International Case-Control Study: A Report From the Genetic Epidemiology of Glioma International Consortium.
TLDR
To the authors' knowledge, the GICC Study is the largest glioma study to date that includes collection of blood samples, which will allow for genetic analysis and interrogation of gene-environment interactions. Expand
Genome-wide association study of prostate cancer identifies a second risk locus at 8q24
TLDR
Observations indicate the presence of at least two independent loci within 8q24 that contribute to prostate cancer in men of European ancestry, and it is estimated that the population attributable risk of the new locus, marked by rs6983267, is higher than the locus marked byrs1447295. Expand
Genome-wide association study identifies 14 novel risk alleles associated with basal cell carcinoma
TLDR
A two-stage genome-wide association study of BCC concludes that candidate genes and non-coding RNAs involved in telomere maintenance, immune regulation and tumour progression, providing deeper insight into the pathogenesis of BCC, are identified. Expand
Personal History of Diabetes, Genetic Susceptibility to Diabetes, and Risk of Brain Glioma: A Pooled Analysis of Observational Studies
TLDR
The results support an inverse association between diabetes history and glioma risk, and the role of genetic susceptibility to diabetes cannot be excluded, and should be pursued in future studies together with other factors that might be responsible for the diabetes–glioma association. Expand
A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer
TLDR
These findings provide new regions for investigation into the pathogenesis of prostate cancer and demonstrate the usefulness of combining ancestrally diverse populations to discover risk loci for disease. Expand
Variants near TERT and TERC influencing telomere length are associated with high-grade glioma risk
TLDR
A new SNP associated with glioma risk, rs1920116 (near TERC), is identified in a meta-analysis of genome-wide association studies of high-grade gliomas and replication data, which implicates telomerase in gliomagenesis. Expand
...
1
2
3
4
5
...